Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral THC and CBD Pharmacokinetics and Effects
NCT05067387Phase 1Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol and cannabidiol (4 arms), sponsored by University of California, Los Angeles. Primary endpoints: Ratings of subjective drug effects at 6 hours, Concentration of THC, CBD and metabolites in whole blood at 6 hours and 2 more. Started Aug 2026; status: recruiting.
02
Drugs
dronabinolcannabidiol
Beyond the preview
Go deeper on NCT05067387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05067387.